ArticleInternational journal of molecular sciences2025
Cat-PIPpred: Pro-Inflammatory Peptide Predictor Integrating CatBoost and Cross-Modal Feature Fusion.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Pro-inflammatory peptides (PIPs) play a pivotal role in the initiation, progression, and sustenance of inflammation. A more in-depth analysis of PIPs requires precise identification, for which computational methodologies have proven to be remarkably cost-effective and accurate. In this study, we introduce Cat-PIPpred, a sophisticated predictor for PIPs that combines CatBoost with cross-modal feature integration. Through a comprehensive evaluation involving cross-validation and independent testing, an optimized model is developed by employing various feature extraction techniques, refinement protocols, and classifier architectures. The integration of ESM-2 structural embeddings with Dipeptide Deviation from Expected Mean (DDE) evolutionary features allows for an extensive representation of sequences. Feature refinement effectively decreases memory consumption while enhancing operational efficiency. The final Cat-PIPpred surpasses existing predictors targeting PIPs, as well as general peptide classifiers. These findings affirm the efficacy of integrating multiple feature sets with advanced ensemble learning algorithms. The proposed framework not only ensures reliable PIP predictions but also offers valuable insights into the functional predictions of specialized peptides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.